UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012

The lancet oncology, 2012-11, Vol.13 (11), p.e482-e491

2012

Volltextzugriff (PDF)

Is there a role for platinum chemotherapy in the treatment of patients with hormone‐refractory prostate cancer?

Cancer, 2007-02, Vol.109 (3), p.477-486

2007

Volltextzugriff (PDF)

Order Effects in the Assessment of Quality of Life in Cancer Patients

Quality of life research, 2004-09, Vol.13 (7), p.1217-1223

2004

Volltextzugriff (PDF)

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

Cancer, 2008-09, Vol.113 (6), p.1332-1337

2008

Volltextzugriff (PDF)

Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in Singapore

Clinical genitourinary cancer, 2015-08, Vol.13 (4), p.e285-e295

2015

Volltextzugriff (PDF)

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A phase II trial using a triplet combination

Cancer, 2005-02, Vol.103 (3), p.569-575

2005

Volltextzugriff (PDF)

Synovial sarcoma of the kidney: a report of 4 cases with pathologic appraisal and differential diagnostic review

Analytical and quantitative cytology and histology, 2010-08, Vol.32 (4), p.239

2010

Volltextzugriff (PDF)

A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma

Clinical cancer research, 2014-12, Vol.20 (23), p.5976-5985

2014

Volltextzugriff (PDF)

Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore

Annals of the Academy of Medicine, Singapore, 2007-10, Vol.36 (10), p.811-814

2007

Volltextzugriff (PDF)

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer

Urology (Ridgewood, N.J.), 2004-02, Vol.63 (2), p.327-332

2004

Volltextzugriff (PDF)

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma

Annals of the Academy of Medicine, Singapore, 2008-07, Vol.37 (7), p.554-558

2008

Volltextzugriff (PDF)

Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification

Ai zheng, 2011-02, Vol.30 (2), p.144-148

2011

Volltextzugriff (PDF)

A multigene expression score for predicting response to anti-PD-1/PD-L1 therapy for clear cell renal cell cancer patients

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.656-656

2019

Volltextzugriff (PDF)

Evaluation and management of hypersensitivity reactions to chemotherapy agents

Postgraduate Medical Journal, 2015-03, Vol.91 (1073), p.145-150

2015

Volltextzugriff (PDF)

Outcomes of Dose-Attenuated Docetaxel in Asian Patients with Castrate-Resistant Prostate Cancer

Annals of the Academy of Medicine, Singapore, 2017-05, Vol.46 (5), p.195-201

2017

Volltextzugriff (PDF)

Adrenal Insufficiency in Intestinal Obstruction from Carcinomatosis Peritonei—A Factor of Potential Importance in Symptom Palliation

Journal of pain and symptom management, 2005-04, Vol.29 (4), p.411-418

2005

Volltextzugriff (PDF)

De-novo EGFR mutation and MET amplification in NSCLC with crizotinib response; a case against one-gene/one-drug paradigm

Annals of oncology, 2015-11, Vol.26, p.vii126

2015

Volltextzugriff (PDF)

Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy

Clinical prostate cancer, 2005-06, Vol.4 (1), p.61-64

2005

Volltextzugriff (PDF)

Metastatic Malignant Phaeochromocytoma: A Rare Entity that Underlies a Therapeutic Quandary

Asian journal of surgery, 2006-10, Vol.29 (4), p.294-302

2006

Volltextzugriff (PDF)

Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer

Annals of the Academy of Medicine, Singapore, 2015-10, Vol.44 (10), p.397-405

2015

Volltextzugriff (PDF)

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC)

Annals of the Academy of Medicine, Singapore, 2015-10, Vol.44 (10), p.406-414

2015

Volltextzugriff (PDF)

Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Annals of the Academy of Medicine, Singapore, 2015-10, Vol.44 (10), p.415-420

2015

Volltextzugriff (PDF)

Randomized phase II study of first-line everolimus plus bevacizumab (E+B) versus interferon α-2a plus bevacizumab (I+B) in patients (pts) with metastatic renal cell carcinoma (mRCC): Record-2 final overall survival (OS) and safety results

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4576-4576

2013

Volltextzugriff (PDF)

Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after chemotherapy

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5061-5061

2014

Volltextzugriff (PDF)

A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

Journal of thoracic oncology, 2007-03, Vol.2 (3), p.230-236

2007

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Englisch
(33)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Male
(19)
Middle Aged
(14)
Female
(12)
General & Internal Medicine
(11)
Medicine, General & Internal
(11)
Adult
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Aged
(8)
Treatment Outcome
(8)
Chemotherapy
(7)
Oncology
(7)
Kidney Neoplasms - Pathology
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Biological And Medical Sciences
(5)
Deoxycytidine - Analogs & Derivatives
(5)
Kidney Cancer
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012

Is there a role for platinum chemotherapy in the treatment of patients with hormone‐refractory prostate cancer?

Order Effects in the Assessment of Quality of Life in Cancer Patients

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in Singapore

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: A phase II trial using a triplet combination

Synovial sarcoma of the kidney: a report of 4 cases with pathologic appraisal and differential diagnostic review

A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma

Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma

Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification

A multigene expression score for predicting response to anti-PD-1/PD-L1 therapy for clear cell renal cell cancer patients

Evaluation and management of hypersensitivity reactions to chemotherapy agents

Outcomes of Dose-Attenuated Docetaxel in Asian Patients with Castrate-Resistant Prostate Cancer

Adrenal Insufficiency in Intestinal Obstruction from Carcinomatosis Peritonei—A Factor of Potential Importance in Symptom Palliation

De-novo EGFR mutation and MET amplification in NSCLC with crizotinib response; a case against one-gene/one-drug paradigm

Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy

Metastatic Malignant Phaeochromocytoma: A Rare Entity that Underlies a Therapeutic Quandary

Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer

Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma (mRCC)

Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Randomized phase II study of first-line everolimus plus bevacizumab (E+B) versus interferon α-2a plus bevacizumab (I+B) in patients (pts) with metastatic renal cell carcinoma (mRCC): Record-2 final overall survival (OS) and safety results

Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after chemotherapy

A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

Suchergebnisse filtern